TP53 mutations as a biomarker for high-grade serous ovarian cancer: Are we there yet?

Derek B. Oien, Jeremy Chien

Research output: Contribution to journalEditorial

6 Scopus citations

Fingerprint Dive into the research topics of 'TP53 mutations as a biomarker for high-grade serous ovarian cancer: Are we there yet?'. Together they form a unique fingerprint.